Recent clinical research from Toronto institutions demonstrates promising results in utilizing ketamine as an innovative therapeutic approach for chronic pain and treatment-resistant depression. A patient previously dependent on 52 daily medications experienced dramatic relief from debilitating pain levels. While preliminary findings suggest significant potential, medical experts emphasize that ketamine's mechanisms and long-term safety profile require further comprehensive investigation to establish standardized protocols and guidelines for widespread clinical implementation.

Summary auto-generated by AI from the original publisher's content. Editorial standards.